Protalix BioTherapeutics will announce its financial results for Q3 2026 on November 10, followed by a conference call and webcast at 8 a.m. ET to discuss recent corporate and regulatory developments. The company specializes in innovative treatments for rare diseases and has partnerships with Pfizer and Chiesi Farmaceutici. Investors can join the call via phone or webcast, with a replay available for two weeks on Protalix's website.
Protalix BioTherapeutics' upcoming Q3 2026 financial results announcement provides context for health sector market activity. For readers following health stocks, 70 out of 150 traded on Pluang rose while 69 fell as of Nov 03, 2026 17:51 WIB. Notable movers include COGT at USD 30.58 with a 2.86% gain and ACB at USD 4.34 with a 2.84% gain, while BKD declined 2.68% to USD 10.16.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
